12.46
3.83%
0.46
Dopo l'orario di chiusura:
12.46
Celcuity Inc Borsa (CELC) Ultime notizie
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Charles Schwab Investment Management Inc. Acquires 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity reports survival data for breast cancer drug - Investing.com
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire
Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com
500: Something went wrong - Investing.com India
Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com
Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey
RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com
Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada
COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com
Celcuity Inc. Reports Q3 Progress and Financials - TipRanks
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update - The Manila Times
Celcuity CEO to Present at Stifel and Jefferies Healthcare Conferences This Month | CELC Stock News - StockTitan
Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - GlobeNewswire
Long Term Trading Analysis for (CELC) - Stock Traders Daily
Celcuity (CELC) Scheduled to Post Earnings on Thursday - MarketBeat
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) to Report Q3 2024 Earnings: Oncology Pipeline Update Coming | CELC Stock News - StockTitan
Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts (NASDAQ:CELC) - Seeking Alpha
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Analysts Set Celcuity Inc. (NASDAQ:CELC) PT at $29.17 - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Short Interest Up 9.3% in October - MarketBeat
Asml Holdings NY Reg ADR (ASML-Q) QuotePress Release - The Globe and Mail
Celcuity director Buller sells $5,687 in stock - Investing.com India
Celcuity director Buller sells $5,687 in stock By Investing.com - Investing.com Australia
Objective long/short (CELC) Report - Stock Traders Daily
Short Interest in Celcuity Inc. (NASDAQ:CELC) Rises By 26.7% - MarketBeat
Celcuity Inc. expands share authorization to 95 million By Investing.com - Investing.com Australia
Celcuity Inc. expands share authorization to 95 million - Investing.com India
Celcuity (NASDAQ:CELC) Files 8-K Disclosing Change in Directors or Principal Officers - MarketBeat
Celcuity (NASDAQ:CELC) Stock Price Down 4.5%Here's What Happened - MarketBeat
Morgan Stanley's Strategic Reduction in Celcuity Inc Holdings - GuruFocus.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):